Bridging with Idelalisib appears safe in patients with chronic lymphocytic leukemia (CLL) prior to allogeneic hematopoietic stem cell transplantation (alloHCT): A Report from the EBMT Chronic Malignancies Working Party

Affiliation auteurs!!!! Error affiliation !!!!
TitreBridging with Idelalisib appears safe in patients with chronic lymphocytic leukemia (CLL) prior to allogeneic hematopoietic stem cell transplantation (alloHCT): A Report from the EBMT Chronic Malignancies Working Party
Type de publicationJournal Article
Year of Publication2017
AuteursSchetelig J., Chevallier P., van Gelder M., Hoek J., Hermine O., Thomson K., Browne P., Milpied N., Russo D., Socie G., Rovira M., Deconinck E., Damaj G., Cordonnier C., Beelen D., Leblond V., Nikolousis M., Stuhler G., Mayer J., Hunault-Berger M., Bittenbring J., Thieblemont C., Lepetre S., de Wreede L.C, Dreger P., Kroeger N.
JournalBONE MARROW TRANSPLANTATION
Volume52
PaginationS99-S100
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN0268-3369